Skip to content
Toggle navigation
Our Company
Our Science
ABC Platform
Scientific Presentations
Focus Areas
Diabetic Eye Disease
Diabetic Retinopathy
Diabetic Macular Edema
Retinal Vein Occlusion
Age-Related Macular Degeneration
Our Pipeline
TARCOCIMAB TEDROMER
KSI-501
KSI-101
Our Culture
Investors & Media
Overview
Press Releases
ESG Report
Events and Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Investor Resources
Our Company
Our Science
ABC Platform
Scientific Presentations
Focus Areas
Diabetic Eye Disease
Diabetic Retinopathy
Diabetic Macular Edema
Retinal Vein Occlusion
Age-Related Macular Degeneration
Our Pipeline
TARCOCIMAB TEDROMER
KSI-501
KSI-101
Our Culture
Investors & Media
Overview
Press Releases
ESG Report
Events and Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Investor Resources
SCIENTIFIC PRESENTATIONS
Explore the breadth and depth of our late and early-phase retina pipeline
OUR PRESENTATIONS
FILTERS
Clear All
Search Presentations
Year of Presentation
Select year
2018
2019
2020
2021
2022
2023
2024
Clinical Program
Tarcocimab tedromer (KSI-301)
KSI-501
KSI-101
Science and Technology
ABC Platform
Platform-Independent
Research Stage
Pre-clinical/non-clinical
Clinical
VIEW RESULTS →
SEARCH RESULTS
